All Pharma News
price-trendAsk Us
Xalud Therapeutics prioritizes gene therapies, with ALS

Xalud Therapeutics prioritizes gene therapies, with ALS
Kyle LaHucik ENDPTS
12 Jun 2023
Share Share
Xalud Therapeutics Presents Clinical Data on XT-150 in Knee Osteoarthritis

Xalud Therapeutics Presents Clinical Data on XT-150 in Knee Osteoarthritis
GLOBENEWSWIRE
20 Mar 2023
Share Share
Xalud Therapeutics CEO to Participate in Two Gene Therapy

Xalud Therapeutics CEO to Participate in Two Gene Therapy
GLOBENEWSWIRE
06 Jun 2022
Share Share
Xalud Tx Doses First Patient in Phase 2a Trial of XT-150 for Osteoarthritis Pain

Xalud Tx Doses First Patient in Phase 2a Trial of XT-150 for Osteoarthritis Pain
BUSINESSWIRE
02 Mar 2022
Share Share
Xalud Receives FDA FTD for XT-150 in Pain Associated with Osteoarthritis

Xalud Receives FDA FTD for XT-150 in Pain Associated with Osteoarthritis
BUSINESSWIRE
17 Dec 2021
Share Share
Immunocore`s bispecific gets speedy review with FDA, EMA; Xalud grabs $30M

Immunocore`s bispecific gets speedy review with FDA, EMA; Xalud grabs $30M
Paul Schloesser\nMax Gelman\nAmber Tong ENDPTS
24 Aug 2021
Share Share
Xalud Therapeutics’ XT-150, Achieves Multiple Clinical Milestones

Xalud Therapeutics’ XT-150, Achieves Multiple Clinical Milestones
BUSINESSWIRE
20 May 2021
Share Share